When immature DCs recognize, uptake, and cross-present the antigens released by tumor cells, they shift to secondary lymphoid organs, where they activate CD4+ T cells or CD8+ T cells to trigger specific CTLs responses against target cells (Wang et al., 2020a). The gene discussed is CD4; the disease is neoplasm.